P Fabris

Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia

Orietta Spinelli, Barbara Peruta, Martina Tosi et al. · Haematologica · 2007 · 130 citations · Full text

Medicine, Hematology, Oncology +13

Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups.

Sergio Amadori, Stefan Suciu, R. Willemze et al. · PubMed · 2004 · 79 citations · Full text

Medicine, Oncology, Pharmacology +17

The relationship between monoclonal myeloma precursor B cells in the peripheral blood stem cell harvests and the clinical response of multiple myeloma patients

Manfred Mitterer, Fuat Oduncu, Andrea Judith Lanthaler et al. · British Journal of Haematology · 1999 · 32 citations · Full text

Life Sciences, Hematology, Immunology +17

Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups.

Renato Bassan, Enrico Pogliani, Paolo Casula et al. · PubMed · 2001 · 31 citations

Medicine, Hematology, Oncology +17

Technetium-99m-sestamibi scintigraphy: an alternative approach for diagnosis and follow-up of active myeloma lesions after high-dose chemotherapy and autologous stem cell transplantation

Mirija Svaldi, C. Tappa, U Gebert et al. · Annals of Hematology · 2001 · 30 citations

Medicine, Nuclear Medicine, Radiology +16